Company DescriptionKaneka Nutrients is a wholly owned subsidiary of Kaneka Corporation, headquartered in Japan. Kaneka manufactures its Kaneka Ubiquinol® and Kaneka Q10® at its plant in Pasadena, TX. Kaneka is the only manufacturer of Ubiquinol and Ubiquinone in the United States.
Since 1977, Kaneka has commercially manufactured the only yeast fermented, all-natural CoQ10, making the product bioidentical to the CoQ10 produced naturally in the body. Ubiquinol is the reduced, active antioxidant form of CoQ10 that is more readily absorbed and used in the body. Our body naturally produces conventional CoQ10 (Ubiquinone) and then converts it to its usable form Ubiquinol, the nutrient essential for cellular energy production and protection against oxidative stress and free radicals. As we age, our body’s ability to produce and convert CoQ10 to its active form Ubiquinol diminishes significantly. Backed by more than 10 years of research, development and testing, Kaneka introduced Ubiquinol and it is the only supplemental Ubiquinol available today.
In 2018, Kaneka invested in AB-Biotics, an innovative biotech company with advanced R&D capability in the field of probiotics. Today, Kaneka is the largest shareholder in AB-Biotics and is the exclusive supplier of AB-Biotics’ probiotic formulations in the North American and Japanese markets. Kaneka’s probiotics perform many roles, including the support of Cardio metabolic, Gastrointestinal, Immune, Infant, Oral, and Women’s health.
Key Market Areas• Heart Health
• Cardiovascular Metabolism
• Gastrointestinal Support
• Immune Health
• Infant Care
• Oral Health
• Women’s Health
Major Products• Kaneka Ubiquinol® is the active anti-oxidant and most bioavailable form of Q10 and is manufactured in the USA.
• Kaneka Q30™ is an encapsulated product providing increased stability beyond that of bulk Ubiquinol and is manufactured in the USA.
• Kaneka Q10® is the highest purity form of conventional Q10 (Ubiquinone) on the market and is manufactured in the USA and Japan.
• Kaneka Probiotic Clinical Strains™ are formulated to impact a variety of health applications, including Cardiovascular health (AB - Life™), Gastrointestinal health (I3.1™), Infant Colic (AB-Kolicare™), Oral health (AB - Dentalac Gum™), Women’s health (AB - Cyscare™), and Immune health (AB - Immuno™)
What’s New?Kaneka Clinical Strain Probiotics™ are expertly formulated probiotic complexes based on a multi-strain approach. These probiotic formulations are at the front line of supporting healthy microbes in the gut ecosystem. These probiotics have been successful in many regions of the world, and Kaneka will distribute these products in the USA and Canada.
The technical advantage of the Kaneka Clinical Strains Probiotics™ comes from their unique ability to secure the most efficacious strains. Utilizing strains isolated from the gut of healthy infants and adults, AB-Biotics focused on a Mechanism of Action (MoA) approach to finding solutions to common health targets.
Kaneka will work with brand holders to help them develop specific products of interest utilizing Kaneka’s Clinical Strain Probiotics™ . In addition, we will work with brand holders’ specific technical parameters like dosage formats and delivery systems (stick packs, sachets, gummies etc.)
Kaneka North America LLCStreet Address: 6250 Underwood Road
Pasadena, Texas 77507
Website:www.kanekanutrients.comLinkedIn:https://www.linkedin.com/company/kaneka-america-llc/Year Founded: 1977
Key PersonnelRichard Weis, Vice President of Sales
Ron Martin, Director of Marketing
Terese Mansell, National Sales Manager
Dr. Fumiki Aoki, Manager - Kaneka / AB Biotics Venture